-SEC Filing
Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Lowers Price Target to $5
Barclays analyst Sarah James maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight and lowers the price target from $7 to $5.
Related Posts
INmune Bio, Inc. Announces Pre-Clinical Data That Support A Pioneering Approach To Treating Duchenne Muscular Dystrophy
INmune Bio, Inc.(NASDAQ:INMB) (the "Company"), a clinical-stage immunology company focused on developing treatments that harness the patient's innate immune system to fight disease, in collaboration with
Keybanc Maintains Overweight on Match Group, Lowers Price Target to $90
Keybanc analyst Justin Patterson maintains Match Group (NASDAQ:MTCH) with a Overweight and lowers the price target from $125 to $90.
Robert Kennedy Jr. Affirms Support For Bitcoin, Promises to Safeguard Individuals’ Rights If Elected As President
Robert Kennedy Jr. on Tuesday reiterated his support for Bitcoin (CRYPTO: BTC).